NCT04102566 Optimizing Pain Control in Transurethral Resection of the Prostate
| NCT ID | NCT04102566 |
| Status | Recruiting |
| Phase | Phase 4 |
| Sponsor | Benaroya Research Institute |
| Condition | Pain |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2017-12-08 |
| Primary Completion | 2019-10-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
Phase 4 studies follow an already-approved treatment in real-world conditions to monitor long-term safety and effectiveness.
This trial targets 50 participants in total. It began in 2017-12-08 with a primary completion date of 2019-10-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to develop a multi-modal protocol for pain management after TURP that minimizes opioid use. The investigators hypothesize this approach will provide non-inferior pain control to the current standard of care which includes opioids as the primary agent. The investigators believe this is an important step in reducing the opioid epidemic in surgical patients.
Eligibility Criteria
Inclusion Criteria: * Are identified as candidates for TURP * Are 18 years of age or greater * Are proficient in English Exclusion Criteria: * Have filled an opioid prescription in the last 2 months * Have an allergy to a medication included in the protocol * Have a history of pelvic radiation * Have renal failure (Serum Cr \> 2.0 mg/dl), peptic ulcer disease, history of gastric bypass, cirrhosis, or other contraindication precluding use of NSAID's * Have liver failure, hepatitis, or alcohol abuse which precludes use of acetaminophen
Contact & Investigator
Frequently Asked Questions
Who can join the NCT04102566 clinical trial?
This trial is open to male participants only, aged 18 Years or older, studying Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
What phase is the NCT04102566 trial and what does that mean for participants?
Phase 4 studies are conducted after a treatment has been approved. They monitor long-term safety and real-world effectiveness in a broader patient population.
Is NCT04102566 currently recruiting?
Yes, NCT04102566 is actively recruiting participants. Contact the research team at ryan.donahue@vmmc.org for enrollment information.
Where is the NCT04102566 trial being conducted?
This trial is being conducted at Seattle, United States.
Who is sponsoring the NCT04102566 clinical trial?
NCT04102566 is sponsored by Benaroya Research Institute. The trial plans to enroll 50 participants.